Cooper JM - Search Results

1

The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.

Cooper JM, Bodemann BO, White MA. Cooper JM, et al. Enzymes. 2013;34 Pt. B:137-56. doi: 10.1016/B978-0-12-420146-0.00006-8. Epub 2013 Nov 7. Enzymes. 2013. PMID: 25034103 Review.

2

Inhibition of Ral GTPases Using a Stapled Peptide Approach.

Thomas JC, Cooper JM, Clayton NS, Wang C, White MA, Abell C, Owen D, Mott HR. Thomas JC, et al. Among authors: cooper jm. J Biol Chem. 2016 Aug 26;291(35):18310-25. doi: 10.1074/jbc.M116.720243. Epub 2016 Jun 22. J Biol Chem. 2016. PMID: 27334922 Free PMC article.

3

TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.

Cooper JM, Ou YH, McMillan EA, Vaden RM, Zaman A, Bodemann BO, Makkar G, Posner BA, White MA. Cooper JM, et al. Cancer Res. 2017 Sep 15;77(18):5077-5094. doi: 10.1158/0008-5472.CAN-17-0829. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716898 Free PMC article.

4

Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote virus detection and cancer.

Zaman A, Wu X, Lemoff A, Yadavalli S, Lee J, Wang C, Cooper J, McMillan EA, Yeaman C, Mirzaei H, White MA, Bivona TG. Zaman A, et al. Cell Rep. 2021 Aug 3;36(5):109491. doi: 10.1016/j.celrep.2021.109491. Cell Rep. 2021. PMID: 34348154 Free PMC article.

5

Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.

Cooper JM, Patel AJ, Chen Z, Liao CP, Chen K, Mo J, Wang Y, Le LQ. Cooper JM, et al. Clin Cancer Res. 2019 Jun 1;25(11):3404-3416. doi: 10.1158/1078-0432.CCR-18-2437. Epub 2019 Feb 22. Clin Cancer Res. 2019. PMID: 30796033 Free PMC article.

6

Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus.

Li W, Cooper J, Karajannis MA, Giancotti FG. Li W, et al. EMBO Rep. 2012 Mar;13(3):204-15. doi: 10.1038/embor.2012.11. EMBO Rep. 2012. PMID: 22482125 Free PMC article. Review.

7

Spatiotemporal Loss of NF1 in Schwann Cell Lineage Leads to Different Types of Cutaneous Neurofibroma Susceptible to Modification by the Hippo Pathway.

Chen Z, Mo J, Brosseau JP, Shipman T, Wang Y, Liao CP, Cooper JM, Allaway RJ, Gosline SJC, Guinney J, Carroll TJ, Le LQ. Chen Z, et al. Among authors: cooper jm. Cancer Discov. 2019 Jan;9(1):114-129. doi: 10.1158/2159-8290.CD-18-0151. Epub 2018 Oct 22. Cancer Discov. 2019. PMID: 30348677 Free PMC article.

8

Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance.

Cooper J, Giancotti FG. Cooper J, et al. Cancer Cell. 2019 Mar 18;35(3):347-367. doi: 10.1016/j.ccell.2019.01.007. Cancer Cell. 2019. PMID: 30889378 Free PMC article. Review.

9

Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis.

Cooper J, Xu Q, Zhou L, Pavlovic M, Ojeda V, Moulick K, de Stanchina E, Poirier JT, Zauderer M, Rudin CM, Karajannis MA, Hanemann CO, Giancotti FG. Cooper J, et al. Mol Cancer Ther. 2017 Aug;16(8):1693-1704. doi: 10.1158/1535-7163.MCT-16-0821. Epub 2017 May 3. Mol Cancer Ther. 2017. PMID: 28468780 Free PMC article.

10

Molecular insights into NF2/Merlin tumor suppressor function.

Cooper J, Giancotti FG. Cooper J, et al. FEBS Lett. 2014 Aug 19;588(16):2743-52. doi: 10.1016/j.febslet.2014.04.001. Epub 2014 Apr 12. FEBS Lett. 2014. PMID: 24726726 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

657 results

Search Page